findmyKOL

Charles Swerdlow, MD

Basic profile

Cedars-Sinai Medical Center

ORCIDNPI
RegionBeverly Hills, CA · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Charles Swerdlow is a Cardiology physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 268 publications with 9,218 citations (h-index 53).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
268publications

Distinct works indexed by OpenAlex, matched via ORCID.

9,218citations

Total citations across indexed works.

53h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

414 N Camden Dr
Ste 1100
Beverly Hills, CA 902104532

Telephone

310-278-3400

Registry record last updated 10 Jun 2010.

View the NPPES registry record

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    73.8%
    Beta blocker19.2%
    Carvedilol42%Metoprolol Tartrate39%Metoprolol Succinate18%
    Part D<11 patients
    Adenosine Receptor Agonist17.5%
    Regadenoson100%
    Part B, office-administered15 patients

    + 5 more classes in this area

  • Blood & clotting

    21%
    Factor Xa inhibitor21%
    Eliquis82%Xarelto18%
    Part D<11 patients
  • Metabolism & gastrointestinal

    5.2%
    SGLT2 inhibitor5.2%
    Jardiance100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”